Align Technology Inc.

ALGN ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $4.03B $4.00B $3.86B $3.73B $3.95B $2.47B $2.41B
Clear Aligner $3.25B $3.23B $3.20B $3.07B $3.25B $2.10B $2.03B
Systems and Services $789.6M $768.9M $662.9M $662.1M $705.5M $370.5M $381.0M
Cost of Revenue $1.32B $1.20B $1.16B $1.10B $1.02B $708.7M $662.9M
Gross Profit $2.71B $2.80B $2.71B $2.63B $2.94B $1.76B $1.74B
Gross Margin 67.2% 70.0% 70.1% 70.5% 74.3% 71.3% 72.5%
Operating Expenses
Research & Development $369.9M $364.2M $346.8M $305.3M $250.3M $175.3M $157.4M
SG&A Expense $1.76B $1.76B $1.70B $1.67B $1.71B $1.20B $1.07B
Operating Income $545.8M $607.6M $643.3M $642.6M $976.4M $387.2M $542.5M
Operating Margin 13.5% 15.2% 16.7% 17.2% 24.7% 15.7% 22.5%
Interest Expense
Pretax Income $585.3M $609.0M $641.2M $599.1M $1.01B $378.9M $562.7M
Income Tax Expense $174.9M $187.6M $196.2M $237.5M $240.4M $-1.40B $112.3M
Net Income $410.4M $421.4M $445.1M $361.6M $772.0M $1.78B $442.8M
Net Margin 10.2% 10.5% 11.5% 9.7% 19.5% 71.8% 18.4%
EPS (Basic) $5.66 $5.63 $5.82 $4.62 $9.78 $22.55 $5.57
EPS (Diluted) $5.65 $5.62 $5.81 $4.61 $9.69 $22.41 $5.53
Shares Outstanding (Basic) 71.3M 72.5M 74.9M 76.4M 78.2M 78.9M 78.8M 79.4M
Shares Outstanding (Diluted) 71.3M 72.6M 75.0M 76.6M 78.4M 79.7M 79.2M 80.1M
Dividends Per Share
← Newer Page 1 of 3 Older →